Clinical Trial Update: Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for LR-ESHAP in Diffuse Large B-cell Lymphoma (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• LR-ESHAP
• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED